Facing an unfortunate trade-off: policy responses, lessons and spill-overs during the COVID-19 pandemic.

COVID-19 GVAR policy stringency sign and magnitude restrictions

Journal

Economics and human biology
ISSN: 1873-6130
Titre abrégé: Econ Hum Biol
Pays: Netherlands
ID NLM: 101166135

Informations de publication

Date de publication:
12 2021
Historique:
received: 16 04 2021
revised: 09 07 2021
accepted: 24 07 2021
pubmed: 2 8 2021
medline: 15 12 2021
entrez: 1 8 2021
Statut: ppublish

Résumé

Although COVID-19 emerged as a global shock, governments adopted non-pharmaceutical policy responses that were rather heterogeneous, depending on cultural and institutional characteristics. At the country level, the stringency of 'lockdown'-type policies should be set to achieve the best possible trade-off between economic and fatality dynamics, obviously accounting for possible cross-border influences. To allow for policy learning, I assume that the first country implementing a policy initiative that is worth emulating must either get the best possible health or the best possible economic outcome. I propose a combination of sign and magnitude restrictions, embedded in a global VAR model, to identify idiosyncratic policy shocks that spill over and influence policy responses abroad. Once policy shocks are identified, I run a comparison exercise between two model specifications, i.e. with and without policy emulation. Within a given a sample, this methodology can be used to find when and where policy lessons can be identified. I find that, among 17 developed and developing countries, few can offer lessons based on their policy initiatives, but several others might get better trade-offs through policy emulation, although in reality this outcome is not guaranteed to have occurred.

Identifiants

pubmed: 34333351
pii: S1570-677X(21)00076-9
doi: 10.1016/j.ehb.2021.101052
pmc: PMC8525467
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101052

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Econ Hum Biol. 2020 Dec;39:100934
pubmed: 33160264
Econ Hum Biol. 2021 Aug;42:101003
pubmed: 33894688
Sci Total Environ. 2021 Jan 1;750:141711
pubmed: 32835962
World Econ. 2020 Jun;43(6):1484-1498
pubmed: 32836720
J Public Econ. 2020 Nov;191:104274
pubmed: 32921841
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):
pubmed: 33443149
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
J Public Econ. 2020 Dec;192:104316
pubmed: 33162621
J Popul Econ. 2021;34(1):223-252
pubmed: 32839640
Econ Hum Biol. 2020 Dec;39:100931
pubmed: 33126025

Auteurs

Catalin Dragomirescu-Gaina (C)

Center for European Studies (CefES), University of Milano-Bicocca, Italy. Electronic address: catalingaina@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH